A MESSAGE FROM THE MANAGEMENT
“The change of management and joining the SGH Healthcaring group will provide fresh impetus for Rovipharm. It will also create opportunities to take advantage of synergies in industrial expertise and R&D. Our combined strength will support our development in the pharmaceutical and medical markets.
Our aim is to become a world leader in administering liquid medicines, against a background of increasingly stringent regulatory constraints and more demands from our customers. Over the next few years, we will be investing heavily in developing the business and our product range to achieve our ambitions.
Rovipharm and Stiplastics have known and admired each other for many years, so bringing the two businesses together was the natural thing to do. It gives Rovipharm the chance to offer a much wider range of solutions for administering liquid medicines. In fact, the group’s companies have highly complementary product ranges and cover most laboratory requirements for medical devices. Nonetheless, we will not lose sight of Rovipharm’s fundamental values: continuing to grow the business at the factory in Ain.”
CEO of Rovipharm
Pôle d’Activités de Lucinges
86, Route du plan d’eau - TREFFORT
01370 VAL-REVERMONT - France